(Q33708467)

28 July 2017

1 reference

title

Body weight gain induced by antipsychotic drugs: mechanisms and management (English)

1 reference

28 July 2017

1 reference

Baptista T

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

Acta Psychiatrica Scandinavica

28 July 2017

published in

1 reference

28 July 2017

volume

100

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

3-16

1 reference

Changes in weight in patients receiving a tranquilizing drug

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

WEIGHT CHANGE DURING AND AFTER HOSPITAL TREATMENT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight as a Correlate of Clinical Response to Psychotropic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight changes with depot neuroleptic maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Depot fluphenazine maintenance treatment and associated weight changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight gain among schizophrenic patients treated with clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Clozapine-induced weight gain: prevalence and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight gain induced by clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Differential effect of clozapine on weight: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight gain associated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Too many chronic mentally disabled patients are too fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Molindone: an indole derivative with antipsychotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight reduction in schizophrenics by molindone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Measurement of appetite disturbances in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Clinical correlates of body weight changes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Weight gain associated with neuroleptic medication: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Endocrine abnormalities of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Insulin resistance: an adaptation for weight maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Metabolic differences and the development of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Puberty modifies sulpiride effects on body weight in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Mechanism of the body weight increase induced by systemic sulpiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Hypophagia after long-term administration of sulpiride in adult female rats: a model of D2 dopamine receptors supersensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Tamoxifen prevents sulpiride-induced weight gain in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Serotonin may play a role in the anorexia induced by amphetamine injections into the lateral hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Effects of cyproheptadine on the feeding and satiety centers in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Hypothalamic sites affecting masticatory neurons in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Intra-nucleus accumbens amphetamine: dose-dependent effects on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Ventromedial hypothalamus vs. lateral hypothalamic D2 satiety receptors in the body weight increase induced by systemic sulpiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Endocrine regulation of food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Use of drugs in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Signals that regulate food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Strategies and potential molecular targets for obesity treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Effect of sulpiride or paroxetine on cerebrospinal fluid neuropeptide concentrations in patients with chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Serum leptin levels increase rapidly after initiation of clozapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Effect of chlorpromazine on blood glucose and plasma insulin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Blood glucose and prolactin in hyperprolactinemic rats exposed to restraint and surgical stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Effect of estrogen on hyperprolactinemia-induced glucose intolerance in SHN mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Antipsychotic drugs and reproductive hormones: relationship to body weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Endocrine and psychological evaluation of women with recent weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Hyperprolactinemia stimulates food intake in the female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Gonadal effects on food intake and adiposity: A metabolic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Metabolic fuels and reproduction in female mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Estradiol inhibits the increase of hypothalamic neuropeptide Y messenger ribonucleic acid expression induced by weight loss in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Withdrawal of [corrected] estrogen increases hypothalamic neuropeptide Y (NPY) mRNA expression in ovariectomized obese rat .

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

A study of the mechanism of weight gain in medroxyprogesterone acetate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Physiological importance of dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Bromocriptine for “negative” schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

The relationship between blood prolactin levels and risk of breast cancer in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1999.TB10908.X

10.1111/J.1600-0447.1999.TB10908.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference